These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 29524130

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
    Waryah CB, Moses C, Arooj M, Blancafort P.
    Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells.
    Mlambo T, Nitsch S, Hildenbeutel M, Romito M, Müller M, Bossen C, Diederichs S, Cornu TI, Cathomen T, Mussolino C.
    Nucleic Acids Res; 2018 May 18; 46(9):4456-4468. PubMed ID: 29538770
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis.
    Kubik G, Summerer D.
    Chembiochem; 2016 Jun 02; 17(11):975-80. PubMed ID: 26972580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modified nucleobase-specific gene regulation using engineered transcription activator-like effectors.
    Tsuji S, Imanishi M.
    Adv Drug Deliv Rev; 2019 Jul 02; 147():59-65. PubMed ID: 31513826
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epigenome Editing in the Brain.
    Bashtrykov P, Jeltsch A.
    Adv Exp Med Biol; 2017 Jul 02; 978():409-424. PubMed ID: 28523558
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Editing the Epigenome: Overview, Open Questions, and Directions of Future Development.
    Rots MG, Jeltsch A.
    Methods Mol Biol; 2018 Jul 02; 1767():3-18. PubMed ID: 29524127
    [Abstract] [Full Text] [Related]

  • 18. Design and Application of DNA Modification-Specific Transcription-Activator-Like Effectors.
    Buchmuller B, Muñoz-López Á, Gieß M, Summerer D.
    Methods Mol Biol; 2021 Jul 02; 2198():381-399. PubMed ID: 32822046
    [Abstract] [Full Text] [Related]

  • 19. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
    Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T, Cathomen T.
    Nucleic Acids Res; 2011 Nov 02; 39(21):9283-93. PubMed ID: 21813459
    [Abstract] [Full Text] [Related]

  • 20. Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression.
    Seem K, Kaur S, Kumar S, Mohapatra T.
    Crit Rev Biochem Mol Biol; 2024 Nov 02; 59(1-2):69-98. PubMed ID: 38440883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.